Blackstone Group Inc., one of the world’s largest investment firms, is nearing a deal to buy Precision Medicine Group for about $2.3 billion, according to people familiar with the matter.
The firm is set to buy a majority stake in the group from existing backers Berkshire Partners and TPG, said the people, who asked not to be identified because they weren’t authorized to speak publicly. No deal has been finalized and Blackstone may choose not to go ahead with the transaction.
Representatives for Blackstone and TPG declined to comment. Representatives for Precision and Berkshire, a Boston-based private equity firm, didn’t respond to requests for comment.
Precision works with pharmaceutical and life sciences companies on clinical trials and to commercialize new products, according to its website.
Source: Bloomberg
Can’t stop reading? Read more
US Pipeline Operator ONEOK Inks Two Deals for $5.9 Billion
US pipeline operator ONEOK Inc. agreed to buy a Permian Basin rival and a controlling stake in...
Blackstone Is Said to Seek A$5.5 Billion Loan for AirTrunk Bid
Private equity firm Blackstone Inc. is in discussions with banks for a five-year loan of about...
Thrive Capital to lead multi-billion dollar OpenAI investment round at $100bn valuation
OpenAI, the company behind the popular AI tool ChatGPT, is in advanced talks to secure several...